Abstract
Background: Wearable cameras are a new type of intervention aimed at stimulating memory in Alzheimer's disease (AD). Such passive external memory aids have started to be considered as alternatives to both more active external aids (such as writing in diaries, journals, and timetables) and to internal cognitive strategies (such as spaced retrieval, errorless learning).
Objective: In order to understand the benefits of these innovative devices for memory compensation, the present experiment examined the effectiveness of two memory training strategies: SenseCam, a wearable camera, a passive external memory aid and a memory training programme (MEMO+) created from tasks known to stimulate memory, in comparison with a control condition, a personal written diary.
Method: Fifty-one patients with mild AD were randomly assigned to one of these three groups. Training lasted for six consecutive weeks, two sessions a week, one hour each, for all groups. Patients underwent a neuropsychological assessment at baseline, after treatment and at follow up (six months later).
Results: Groups showed non-significant differences at baseline. After treatment and at follow up, the SenseCam group had a superior autobiographical memory (AM) performance, compared to the Memo+ and Diary groups. The SenseCam and the Memo+ groups both showed improved episodic and semantic memory, and somewhat improved executive function.
Conclusion: Our results suggest that passive memory training with SenseCam is a promising alternative to traditional memory training programs to help AD patients with autobiographical memory performance.
Keywords: Alzheimer's disease, memory, cognitive training, wearable cameras, non-pharmacological interventions, Sense- Cam.
Current Alzheimer Research
Title:The Cognitive Effects of Wearable Cameras in Mild Alzheimer Disease – An Experimental Study
Volume: 14 Issue: 12
Author(s): Ana Rita Silva*, Maria Salome Pinho , Luis Macedo and Christopher J.A. Moulin
Affiliation:
- Faculty of Psychology and Educational Sciences of the University of Coimbra, CINEICC – Cognitive and Behavioural Center for Research and Intervention, Colegio Novo Street, s/n, 3001-802 Coimbra,Portugal
Keywords: Alzheimer's disease, memory, cognitive training, wearable cameras, non-pharmacological interventions, Sense- Cam.
Abstract: Background: Wearable cameras are a new type of intervention aimed at stimulating memory in Alzheimer's disease (AD). Such passive external memory aids have started to be considered as alternatives to both more active external aids (such as writing in diaries, journals, and timetables) and to internal cognitive strategies (such as spaced retrieval, errorless learning).
Objective: In order to understand the benefits of these innovative devices for memory compensation, the present experiment examined the effectiveness of two memory training strategies: SenseCam, a wearable camera, a passive external memory aid and a memory training programme (MEMO+) created from tasks known to stimulate memory, in comparison with a control condition, a personal written diary.
Method: Fifty-one patients with mild AD were randomly assigned to one of these three groups. Training lasted for six consecutive weeks, two sessions a week, one hour each, for all groups. Patients underwent a neuropsychological assessment at baseline, after treatment and at follow up (six months later).
Results: Groups showed non-significant differences at baseline. After treatment and at follow up, the SenseCam group had a superior autobiographical memory (AM) performance, compared to the Memo+ and Diary groups. The SenseCam and the Memo+ groups both showed improved episodic and semantic memory, and somewhat improved executive function.
Conclusion: Our results suggest that passive memory training with SenseCam is a promising alternative to traditional memory training programs to help AD patients with autobiographical memory performance.
Export Options
About this article
Cite this article as:
Silva Rita Ana*, Pinho Salome Maria , Macedo Luis and Moulin J.A. Christopher, The Cognitive Effects of Wearable Cameras in Mild Alzheimer Disease – An Experimental Study, Current Alzheimer Research 2017; 14 (12) . https://dx.doi.org/10.2174/1567205014666170531083015
DOI https://dx.doi.org/10.2174/1567205014666170531083015 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
New Advances in the Prevention, Diagnosis, Treatment, and Rehabilitation of Alzheimer's Disease
Aims and Scope: Introduction: Alzheimer's disease (AD) poses a significant global health challenge, with an increasing prevalence that demands concerted efforts to advance our understanding and strategies for prevention, diagnosis, treatment, and rehabilitation. This thematic issue aims to bring together cutting-edge research and innovative approaches from multidisciplinary perspectives to address ...read more
Alzheimer's Disease Drug Development
Alzheimer's disease is a progressive neurodegenerative disorder that affects millions of people worldwide. Despite decades of research, no cure or disease-modifying treatment is available yet. Therefore, the need for developing effective therapies to treat Alzheimer's disease is an urgent matter. This special issue aims to provide a comprehensive overview of ...read more
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer?s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Deep Learning for Advancing Alzheimer's Disease Research
Alzheimer's disease (AD) poses a significant global health challenge, with an increasing number of individuals affected yearly. Deep learning, a subfield of artificial intelligence, has shown immense potential in various domains, including healthcare. This thematic issue of Current Alzheimer Research explores the application of deep learning techniques in advancing our ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Heterogeneity in Cost-Effectiveness Analysis of Vaccination for Mild and Moderate Alzheimer’s Disease
Current Alzheimer Research Targeting the Secretory Pathway for Anti-Inflammatory Drug Development
Current Topics in Medicinal Chemistry Translocator Protein Ligands as Promising Therapeutic Tools for Anxiety Disorders
Current Medicinal Chemistry Lung Cancer Brachytherapy: Robotics-Assisted Minimally Invasive Approach
Current Respiratory Medicine Reviews The Problem of False-Positive Human Papillomavirus DNA Tests in Cervical Screening
Current Pharmaceutical Design Respiratory Viruses, Eosinophil Activation, and Early Allergen Sensitization - Early Life Predictors of Persistent Wheezing and Asthma
Current Pediatric Reviews IL28B Polymorphism, Blood Interferon-Alpha Concentration, and Disease Stage of HCV Mono-Infected and HCV-HIV Co-Infected Patients
Current HIV Research IDO and Clinical Conditions Associated with Depressive Symptoms
Current Drug Metabolism Endocannabinoid System: A Multi-Facet Therapeutic Target
Current Clinical Pharmacology Dehydroevodiamine•HCl Protects Against Memory Impairment and Cerebral Amyloid-β Production in Tg2576 Mice by Acting as a β-Secretase Inhibitor
CNS & Neurological Disorders - Drug Targets L-Dopa Related Hyperhomocysteinemia: A Possible Mediator of Toxicity?
Letters in Drug Design & Discovery Effects of Eugenol on the Central Nervous System: Its Possible Application to Treatment of Alzheimers Disease, Depression, and Parkinsons Disease
Current Bioactive Compounds Imaging Epigenetics in Alzheimer’s Disease
Current Pharmaceutical Design Meet Our Editorial Board Member
Recent Patents on Inflammation & Allergy Drug Discovery Brain Permeable Nanoparticles
Recent Patents on CNS Drug Discovery (Discontinued) New Molecular and Cellular Targets for Chemoprevention and Treatment of Skin Tumors by Plant Polyphenols: A Critical Review
Current Medicinal Chemistry Heat Shock Proteins: Old and Novel Roles in Neurodegenerative Diseases in the Central Nervous System
CNS & Neurological Disorders - Drug Targets From Surface to Nuclear Receptors: The Endocannabinoid Family Extends its Assets
Current Medicinal Chemistry From the Editors Perspective: Rational Approaches for Radical Entities
Current Neurovascular Research Meet Our Editorial Board Member
Current Neuropharmacology